Brief: Pharnext Announces Dr. David Horn Solomon Resignation From His Duties as CEO and Director, Appoints Joshua Schafer As Interim CEO and Dr. Jim Kuo As Director
Nov 28 (Reuters) - Pharnext SA PHARN.PA :
* THE BOARD OF DIRECTORS OF PHARNEXT ACKNOWLEDGES THE
RESIGNATION
OF DR. DAVID HORN SOLOMON FROM HIS DUTIES AS CHIEF EXECUTIVE
OFFICER AND DIRECTOR OF THE COMPANY
* EFFECTIVE NOVEMBER 27TH, 2022, JOSHUA SCHAFER WILL SERVE
AS
INTERIM CEO WHILE RETAINING HIS ROLE AS CHAIRMAN OF BOARD
* BOARD OF DIRECTORS HAS CHOSEN DR. JIM KUO, CURRENTLY
OBSERVER OF
COMPANY, TO IMMEDIATELY SUCCEED DR. DAVID HORN SOLOMON AS
DIRECTOR
Source text for Eikon: ID:nEQ1l7Lqna
Further company coverage: PHARN.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Pharnext SCA
See all newsBrief: Pharnext Progresses On Charcot-Marie-Tooth Disease Study
Brief: Pharnext Reports Topline Results From Pivotal Phase III Clinical Trial Of PXT3003 In Charcot-Marie-Tooth Disease Type 1A
Brief: Pharnext Receives Offer Valuing Its Drug Candidate For Charcotmarie-Tooth Disease At Over Eur 500 Mln
Brief: Pharnext Appoints Dr Gilbert Wagener As Chief Medical Officer
Brief: Pharnext Reports Significant Progress In Search For Pharmaceutical Partners To Finance Its Development